ZYME:NASDAQ, Zymeworks Inc.

ZYME stock overview

Zymeworks Inc. (ZYME:NASDAQ) closed at $26.86 on November 19, 2026, up 3.15% on the day. The stock trades 16.0% below its 52-week high of $31.97 and 24.8% above its 52-week low of $21.52. Over the past year, it gained 12.8%. Zymeworks Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$26.86
Day change
+3.15%
Volume
993,081
Average volume
1,082,840
Market cap
1B+
52-week range
$21.52 – $31.97
50-day average
$27.20
200-day average
$25.57

Price action over the past year

In 252 trading sessions since November 19, 2025, ZYME closed higher on 131 days (52%). Its best day was June 30, 2026 (+8.46%) and its worst was May 8, 2026 (-10.19%). The stock moved 10% or more in a single session 1 time.

Recent signals

ZYME news

About Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.

Similar stocks

Find more stocks like ZYME with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.